Prenatal screening for structural congenital heart disease

Nature Reviews Cardiology

Volumn 11, Issue 6, 2014, Pages 323-334

  Hunter, Lindsey E ^a   Simpson, John M ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE STENOSIS; ARTERIAL OXYGEN SATURATION; ARTERIAL TRUNK; BODY MASS; CHROMOSOME ABERRATION; CHROMOSOME DELETION 22Q11; COMORBIDITY; CONGENITAL HEART DISEASE; CRITICALLY ILL PATIENT; DECISION MAKING; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; FAMILY HISTORY; FETUS CIRCULATION; GREAT VESSELS TRANSPOSITION; HEART INJURY; HEART VALVE STENOSIS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; LOW RISK POPULATION; LUNG VASCULAR RESISTANCE; LUNG VEIN DRAINAGE ANOMALY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SHOCK; TELEMEDICINE; TRISOMY 21;

FEMALE; FETAL HEART; FETUS; HEART DEFECTS, CONGENITAL; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 84901493740     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.34     Document Type: Review

References (128)

1. Hoffman, J. I. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr. Cardiol. 16, 155-165 (1995).
2. Hoffman, J. I. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890-1900 (2002). (Pubitemid 34628268)
3. Wren, C., Richmond, S. & Donaldson, L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 83, 414-419 (2000). (Pubitemid 30316755)
4. Jenkins, K. J. et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115, 2995-3014 (2007). (Pubitemid 46912106)
5. Carvalho, J. S. et al. ISUOG practice guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet. Gynecol. 41, 348-359 (2013).
6. Rychik, J. et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J. Am. Soc. Echocardiogr. 17, 803-810 (2004). (Pubitemid 38858033)
7. The American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of fetal echocardiography. J. Ultrasound Med. 30, 127-136 (2011).
8. Allan, L. et al. Recommendations for the practice of fetal cardiology in Europe. Cardiol. Young 14, 109-114 (2004).
9. Public Health England. NHS Fetal Anomaly Screening Programme: Standards and Policies [online], http://fetalanomaly. screening. nhs. uk/ standardsandpolicies (2014).
10. Hyett, J., Perdu, M., Sharland, G., Snijders, R. & Nicolaides, K. H. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study. BMJ 318, 81-85 (1999). (Pubitemid 29188923)
11. Ghi, T., Huggon, I., Zosmer, N. & Nicolaides, K. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet. Gynecol. 18, 610-614 (2001). (Pubitemid 34063060)
12. Zosmer, N., Souter, V., Chan, C., Huggon, I. & Nicolaides, K. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br. J. Obstet. Gynaecol. 106, 829-833 (1999). (Pubitemid 29361210)
13. Makrydimas, G. et al. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers. Am. J. Obstet. Gynecol. 192, 89-95 (2005). (Pubitemid 40164225)
14. Sotiriadis, A., Papatheodorou, S., Eleftheriades, M. & Makrydimas, G. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: A meta-analysis. Ultrasound Obstet. Gynecol. 42, 383-389 (2013).
15. Pereira, S., Ganapathy, R., Syngelaki, A., Maiz, N. & Nicolaides, K. H. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet. Gynecol. 117, 1384-1391 (2011).
16. Maiz, N., Plasencia, W., Dagklis, T., Faros, E. & Nicolaides, K. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet. Gynecol. 31, 256-260 (2008).
17. Maiz, N. & Nicolaides, K. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications. Fetal Diagn. Ther. 28, 65-71 (2010).
18. Morain, S., Greene, M. & Mello, M. A new era in noninvasive prenatal testing. N. Engl. J. Med. 369, 499-501 (2013).
19. Gil, M., Quezada, M., Bregant, B., Ferraro, M. & Nicolaides, K. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet. Gynecol. 42, 34-40 (2013).
20. Nicolaides, K., Syngelaki, A., Poon, L., Gil, M. & Wright, D. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn. Ther. http://dx. doi. org/10. 1159/000356066.
21. Gardiner, H. First-trimester fetal echocardiography: routine practice or research tool? Ultrasound Obstet. Gynecol. 42, 611-612 (2013).
22. Gill, H., Splitt, M., Sharland, G. & Simpson, J. Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J. Am. Coll. Cardiol. 42, 923-929 (2003). (Pubitemid 37059755)
23. Burn, J. et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351, 311-316 (1998). (Pubitemid 28052695)
24. Fesslova, V. et al. Recurrence of congenital heart disease in cases with familial risk screened prenatally by echocardiography. J. Pregnancy 2011, 368067 (2011).
25. Allan, L., Crawford, D., Chita, S., Anderson, R. & Tynan, M. Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am. J. Cardiol. 58, 334-337 (1986). (Pubitemid 16052728)
26. Hinton, R. et al. Hypoplastic left heart syndrome is heritable. J. Am. Coll. Cardiol. 50, 1590-1595 (2007).
27. Alonso, S. et al. Heterotaxia syndrome and autosomal dominant inheritance. Am. J. Med. Genet. 56, 12-15 (1995).
28. Yagel, S., Cohen, S. M. & Achiron, R. Examination of the fetal heart by five short-axis views: A proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet. Gynecol. 17, 367-369 (2001). (Pubitemid 32499865)
29. Bull, C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet 354, 1242-1247 (1999). (Pubitemid 29469352)
30. Levy, D. et al. Improved prenatal detection of congenital heart disease in an integrated health care system. Pediatr. Cardiol. 34, 670-679 (2013).
31. Allan, L. Antenatal diagnosis of heart disease. Heart 83, 367 (2000).
32. Gilboa, S. et al. Association between prepregnancy body mass index and congenital heart defects. Am. J. Obstet. Gynecol. 202, 510 (2010).
33. Hunter, S., Heads, A., Wyllie, J. & Robson, S. Prenatal diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonographers. Heart 84, 294-298 (2000).
34. McBrien, A., Sands, A., Craig, B., Dornan, J. & Casey, F. Impact of a regional training program in fetal echocardiography for sonographers on the antenatal detection of major congenital heart disease. Ultrasound Obstet. Gynecol. 36, 279-284 (2010).
35. Sharland, G. Routine fetal cardiac screening: what are we doing and what should we do? Prenat. Diagn. 24, 1123-1129 (2004). (Pubitemid 40053035)
36. Sharland, G. & Allan, L. Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region. Br. J. Obstet. Gynaecol. 99, 220-225 (1992).
37. Jaudi, S. et al. Online audit and feedback improve fetal second-trimester four-chamber view images: A randomised controlled trial. Prenat. Diagn. 33, 959-964 (2013).
38. Jegatheeswaran, A. et al. Costs of prenatal detection of congenital heart disease. Am. J. Cardiol. 108, 1808-1814 (2011).
39. Gardiner, H. et al. Prenatal screening for major congenital heart disease: Assessing performance by combining national cardiac audit with maternity data. Heart 100, 375-382 (2014).
40. Marek, J., Tomek, V., Skovranek, J., Povysilova, V. & Samanek, M. Prenatal ultrasound screening of congenital heart disease in an unselected national population: A 21-year experience. Heart 97, 124-130 (2011).
41. Allan, L. et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J. Am. Coll. Cardiol. 23, 1452-1458 (1994). (Pubitemid 24158017)
42. Jowett, V. et al. Sonographic predictors of surgery in fetal coarctation of the aorta. Ultrasound Obstet. Gynecol. 40, 47-54 (2012).
43. Sharland, G., Chan, K. & Allan, L. Coarctation of the aorta: difficulties in prenatal diagnosis. Br. Heart J. 71, 70-75 (1994). (Pubitemid 24061014)
44. Hornberger, L., Sahn, D., Kleinman, C., Copel, J. & Silverman, N. Antenatal diagnosis of coarctation of the aorta: A multicenter experience. J. Am. Coll. Cardiol. 23, 417-423 (1994). (Pubitemid 24049374)
45. Matsui, H., Mellander, M., Roughton, M., Jicinska, H. & Gardiner, H. Morphological and physiological predictors of fetal aortic coarctation. Circulation 118, 1793-1801 (2008).
46. Pasquini, L. et al. Z-scores of the fetal aortic isthmus and duct: An aid to assessing arch hypoplasia. Ultrasound Obstet. Gynecol. 29, 628-633 (2007).
47. Chubb, H. & Simpson, J. The use of Z-scores in paediatric cardiology. Ann. Pediatr. Cardiol. 5, 179-184 (2012).
48. Head, C., Jowett, V., Sharland, G. & Simpson, J. Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life. Heart 91, 1070-1074 (2005). (Pubitemid 41060018)
49. Allan, L. & Sharland, G. The echocardiographic diagnosis of totally anomalous pulmonary venous connection in the fetus. Heart 85, 433-437 (2001). (Pubitemid 32973533)
50. Feller Printz, B. & Allan, L. Abnormal pulmonary venous return diagnosed prenatally by pulsed Doppler flow imaging. Ultrasound Obstet. Gynecol. 9, 347-349 (1997). (Pubitemid 27303316)
51. Seale, A. et al. Total anomalous pulmonary venous connection: Impact of prenatal diagnosis. Ultrasound Obstet. Gynecol. 40, 310-318 (2012).
52. Yamamoto, Y. & Hornberger, L. Progression of outflow tract obstruction in the fetus. Early Hum. Dev. 88, 279-285 (2012).
53. Johnson, P., Maxwell, D. J., Tynan, M. J. & Allan, L. D. Intracardiac pressures in the human fetus. Heart 84, 59-63 (2000). (Pubitemid 30429223)
54. Mosimann, B., Zidere, V., Simpson, J. & Allan, L. Outcome and requirement for surgical repair following prenatal diagnosis of ventricular septal defect. Ultrasound Obstet. Gynecol. http://dx. doi. org/10. 1002/uog. 13284.
55. Paladini, D. et al. Characterization and natural history of ventricular septal defects in the fetus. Ultrasound Obstet. Gynecol. 16, 118-122 (2000). (Pubitemid 33111769)
56. Carvalho, J., Moscoso, G. & Ville, Y. First-trimester transabdominal fetal echocardiography. Lancet 351, 1023-1027 (1998). (Pubitemid 28154379)
57. Carvalho, M. et al. Detection of fetal structural abnormalities at the 11-14 week ultrasound scan. Prenat. Diagn. 22, 1-4 (2002). (Pubitemid 34146039)
58. Yagel, S., Cohen, S. & Messing, B. First and early second trimester fetal heart screening. Curr. Opin. Obstet. Gynecol. 19, 183-190 (2007). (Pubitemid 46412108)
59. Simpsom, J., Jones, A., Callaghan, N. & Sharland, G. Accuracy and limitations of transabdominal fetal echocardiography at 12-15 weeks of gestation in a population at high risk for congenital heart disease. BJOG 107, 1492-1497 (2000). (Pubitemid 32047481)
60. Persico, N. et al. Fetal echocardiography at 11-13 weeks by transabdominal high-frequency ultrasound. Ultrasound Obstet. Gynecol. 37, 296-301 (2011).
61. Zidere, V., Bellsham-Revell, H., Persico, N. & Allan, L. Comparison of echocardiographic findings in fetuses at less than 15 weeks' gestation with later cardiac evaluation. Ultrasound Obstet. Gynecol. 42, 679-686 (2013).
62. Arya, B., Glickstein, J., Levasseur, S. & Williams, I. Parents of children with congenital heart disease prefer more information than cardiologists provide. Congenit. Heart Dis. 8, 78-85 (2013).
63. Prsa, M., Holly, C., Carnevale, F., Justino, H. & Rohlicek, C. Attitudes and practices of cardiologists and surgeons who manage HLHS. Pediatrics 125, e625-e630 (2010).
64. Kon, A., Ackerson, L. & Lo, B. How pediatricians counsel parents when no "best-choice" management exists: lessons to be learned from hypoplastic left heart syndrome. Arch. Pediatr. Adolesc. Med. 158, 436-441 (2004). (Pubitemid 38623579)
65. Williams, I. A. et al. Parental understanding of neonatal congenital heart disease. Pediatr. Cardiol. 29, 1059-1065 (2008).
66. Hilton-Kamm, D., Chang, R.-K. & Sklansky, M. Prenatal diagnosis of hypoplastic left heart syndrome: Impact of counseling patterns on parental perceptions and decisions regarding termination of pregnancy. Pediatr. Cardiol. 33, 1402-1410 (2012).
67. Hilton-Kamm, D., Sklansky, M. & Chang, R.-K. How not to tell parents about their child's new diagnosis of congenital heart disease: An Internet survey of 841 parents. Pediatr. Cardiol. 35, 239-252 (2014).
68. Marino, B. et al. Quality-of-life concerns differ among patients, parents, and medical providers in children and adolescents with congenital and acquired heart disease. Pediatrics 123, e708-e715 (2009).
69. Langford, K., Sharland, G. & Simpson, J. Relative risk of abnormal karyotype in fetuses found to have an atrioventricular septal defect (AVSD) on fetal echocardiography. Prenat. Diagn. 25, 137-139 (2005). (Pubitemid 40327394)
70. Pepas, L. P. et al. An echocardiographic study of tetralogy of Fallot in the fetus and infant. Cardiol. Young 13, 240-247 (2003). (Pubitemid 41630888)
71. Sharland, G. What should be provided by a service for fetal cardiology? Cardiol. Young 10, 625-635 (2000).
72. Rempel, G., Cender, L., Lynam, M., Sandor, G. & Farquharson, D. Parents' perspectives on decision making after antenatal diagnosis of congenital heart disease. J. Obstet. Gynecol. Neonatal Nurs. 33, 64-70 (2004). (Pubitemid 40883453)
73. Brosig, C. L., Whitstone, B. N., Frommelt, M. A., Frisbee, S. J. & Leuthner, S. R. Psychological distress in parents of children with severe congenital heart disease: the impact of prenatal versus postnatal diagnosis. J. Perinatol. 27, 687-692 (2007). (Pubitemid 350020348)
74. Tworetzky, W. et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 103, 1269-1273 (2001). (Pubitemid 32221351)
75. Sivarajan, V., Penny, D. J., Filan, P., Brizard, C. & Shekerdemian, L. S. Impact of antenatal diagnosis of hypoplastic left heart syndrome on the clinical presentation and surgical outcomes: the Australian experience. J. Paediatr. Child Health 45, 112-117 (2009).
76. Kumar, R. K., Newburger, J. W., Gauvreau, K., Kamenir, S. A. & Hornberger, L. K. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am. J. Cardiol. 83, 1649-1653 (1999). (Pubitemid 29288009)
77. Mahle, W., Clancy, R., McGaurn, S., Goin, J. & Clark, B. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics 107, 1277-1282 (2001). (Pubitemid 32525202)
78. Franklin, O. et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 87, 67-69 (2002). (Pubitemid 34074958)
79. Bonnet, D. et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 99, 916-918 (1999). (Pubitemid 29094306)
80. Jouannic, J.-M. et al. Sensitivity and specificity of prenatal features of physiological shunts to predict neonatal clinical status in transposition of the great arteries. Circulation 110, 1743-1746 (2004). (Pubitemid 39299215)
81. Tzifa, A., Barker, C., Tibby, S. M. & Simpson, J. M. Prenatal diagnosis of pulmonary atresia: Impact on clinical presentation and early outcome. Arch. Dis. Child. Fetal Neonatal Ed. 92, F199-F203 (2007). (Pubitemid 46698117)
82. Mats, M. & Jan, S. Failure to diagnose critical heart malformations in newborns before discharge-an increasing problem? Acta Paediatrica 95 (2007).
83. Ewer, A. et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): A test accuracy study. Lancet 378, 785-794 (2011).
84. Rogers, L. et al. Mitral valve dysplasia syndrome: A unique form of left-sided heart disease. J. Thorac. Cardiovasc. Surg. 142, 1381-1387 (2011).
85. Vogel, M. et al. Aortic stenosis and severe mitral regurgitation in the fetus resulting in giant left atrium and hydrops: Pathophysiology, outcomes, and preliminary experience with pre-natal cardiac intervention. J. Am. Coll. Cardiol. 57, 348-355 (2011).
86. Divanovic, A. et al. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: clinical experience using pulmonary venous Doppler analysis. J. Thorac. Cardiovasc. Surg. 141, 988-994 (2011).
87. Michelfelder, E., Gomez, C., Border, W., Gottliebson, W. & Franklin, C. Predictive value of fetal pulmonary venous flow patterns in identifying the need for atrial septoplasty in the newborn with hypoplastic left ventricle. Circulation 112, 2974-2979 (2005). (Pubitemid 41612300)
88. Simpson, J. & Sharland, G. Natural history and outcome of aortic stenosis diagnosed prenatally. Heart 77, 205-210 (1997). (Pubitemid 27122769)
89. Mäkikallio, K. et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: Patient selection for fetal intervention. Circulation 113, 1401-1405 (2006). (Pubitemid 43739436)
90. Gardiner, H. M. et al. Morphologic and functional predictors of eventual circulation in the fetus with pulmonary atresia or critical pulmonary stenosis with intact septum. J. Am. Coll. Cardiol. 51, 1299-1308 (2008). (Pubitemid 351400900)
91. Salvin, J. W. et al. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics 118, e415-e420 (2006). (Pubitemid 46085380)
92. Andrews, R. E., Tibby, S. M., Sharland, G. K. & Simpson, J. M. Prediction of outcome of tricuspid valve malformations diagnosed during fetal life. Am. J. Cardiol. 101, 1046-1050 (2008).
93. Fouron, J. C. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat. Diagn. 24, 1068-1080 (2004).
94. Jaeggi, E. T. et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124, 1747-1754 (2011).
95. Simpson, J. M. & Sharland, G. K. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 79, 576-581 (1998). (Pubitemid 28289280)
96. Jaeggi, E. et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110, 1542-1548 (2004). (Pubitemid 39297974)
97. Rosenthal, E., Gordon, P. A., Simpson, J. M. & Sharland, G. K. Letter regarding article by Jaeggi et al., "transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease". Circulation 111, e287-e288 (2005).
98. Eliasson, H. et al. Isolated atrioventricular block in the fetus: A retrospective, multinational, multicenter study of 175 patients. Circulation 124, 1919-1926 (2011).
99. McElhinney, D. et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation 120, 1482-1490 (2009).
100. McElhinney, D., Tworetzky, W. & Lock, J. Current status of fetal cardiac intervention. Circulation 121, 1256-1263 (2010).
101. Arzt, W. et al. Intrauterine aortic valvuloplasty in fetuses with critical aortic stenosis: Experience and results of 24 procedures. Ultrasound Obstet. Gynecol. 37, 689-695 (2011).
102. Makikallio, K. et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: Patient selection for fetal intervention. Circulation 113, 1401-1405 (2006). (Pubitemid 43739436)
103. Tworetzky, W. et al. Balloon dilation of severe aortic stenosis in the fetus: Potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 110, 2125-2131 (2004). (Pubitemid 39372489)
104. Emani, S. M. et al. Staged left ventricular recruitment after single-ventricle palliation in patients with borderline left heart hypoplasia. J. Am. Coll. Cardiol. 60, 1966-1974 (2012).
105. Friedman, K. G. et al. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. Am. J. Cardiol. 108, 556-560 (2011).
106. Simpson, J. M. Fetal cardiac interventions: worth it? Heart 95, 1653-1655 (2009).
107. Tulzer, G. et al. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 360, 1567-1568 (2002). (Pubitemid 35356374)
108. Tworetzky, W. et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes. Pediatrics 124, e510-e518 (2009).
109. Rychik, J., Rome, J. J., Collins, M. H., DeCampli, W. M. & Spray, T. L. The hypoplastic left heart syndrome with intact atrial septum: Atrial morphology, pulmonary vascular histopathology and outcome. J. Am. Coll. Cardiol. 34, 554-560 (1999).
110. Seed, M., Bradley, T., Bourgeois, J., Jaeggi, E. & Yoo, S. J. Antenatal MR imaging of pulmonary lymphangiectasia secondary to hypoplastic left heart syndrome. Pediatr. Radiol. 39, 747-749 (2009).
111. Marshall, A. C. et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Prenat. Diagn. 28, 1023-1028 (2008). (Pubitemid 352789468)
112. Kalish, B. T. et al. Technical challenges of atrial septal stent placement in fetuses with hypoplastic left heart syndrome and intact atrial septum. Catheter. Cardiovasc. Interv. http://dx. doi. org/10. 1002/ccd. 25098.
113. Chaturvedi, R. R., Ryan, G., Seed, M., van Arsdell, G. & Jaeggi, E. T. Fetal stenting of the atrial septum: technique and initial results in cardiac lesions with left atrial hypertension. Int. J. Cardiol. 168, 2029-2036 (2013).
114. Vida, V. et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann. Thorac. Surg. 84, 581-585 (2007).
115. Warrier, D., Saraf, R., Maheshwari, S., Suresh, P. & Shah, S. Awareness of fetal echo in Indian scenario. Ann. Pediatr. Cardiol. 5, 156-159 (2012).
116. Vaidyanathan, B., Kumar, S., Sudhakar, A. & Kumar, R. K. Conotruncal anomalies in the fetus: referral patterns and pregnancy outcomes in a dedicated fetal cardiology unit in South India. Ann. Pediatr. Cardiol. 6, 15-20 (2013).
117. Thangaratinam, S., Brown, K., Zamora, J., Khan, K. S. & Ewer, A. K. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: A systematic review and meta-analysis. Lancet 379, 2459-2464 (2012).
118. Sairam, S. & Carvalho, J. Early fetal echocardiography and anomaly scan in fetuses with increased nuchal translucency. Early Hum. Dev. 88, 269-272 (2012).
119. Adriaanse, B. et al. Interobserver agreement in detailed prenatal diagnosis of congenital heart disease by telemedicine using four-dimensional ultrasound with spatiotemporal image correlation. Ultrasound Obstet. Gynecol. 39, 203-209 (2012).
120. Zidere, V., Pushparajah, K., Allan, L. D. & Simpson, J. M. Three-dimensional fetal echocardiography for prediction of postnatal surgical approach in double outlet right ventricle: A pilot study. Ultrasound Obstet. Gynecol. 42, 421-425 (2013).
121. Viñals, F. Current experience and prospect of internet consultation in fetal cardiac ultrasound. Fetal Diagn. Ther. 30, 83-87 (2011).
122. Viñals, F., Poblete, P. & Giuliano, A. Spatio-temporal image correlation (STIC): A new tool for the prenatal screening of congenital heart defects. Ultrasound Obstet. Gynecol. 22, 388-394 (2003). (Pubitemid 37289768)
123. Yeo, L. & Romero, R. Fetal Intelligent Navigation Echocardiography (FINE): A novel method for rapid, simple, and automatic examination of the fetal heart. Ultrasound Obstet. Gynecol. 42, 268-284 (2013).
124. McCrossan, B. A., Sands, A. J., Kileen, T., Cardwell, C. R. & Casey, F. A. Fetal diagnosis of congenital heart disease by telemedicine. Arch. Dis. Child. Fetal Neonatal Ed. 96, F394-F397 (2011).
125. McCrossan, B. A., Sands, A. J., Kileen, T., Doherty, N. N. & Casey, F. A. A fetal telecardiology service: Patient preference and socio-economic factors. Prenat. Diagn. 32, 883-887 (2012).
126. Seed, M. et al. Feasibility of quantification of the distribution of blood flow in the normal human fetal circulation using CMR: A cross-sectional study. J. Cardiovasc. Magn. Reson. 14, 79 (2012).
127. Manganaro, L. et al. Magnetic resonance imaging of fetal heart: Anatomical and pathological findings. J. Matern. Fetal Neonatal Med. http://dx. doi. org/10. 3109/14767058. 2013. 852174.
128. Wielandner, A., Mlczoch, E., Prayer, D. & Berger-Kulemann, V. Potential of magnetic resonance for imaging the fetal heart. Semin. Fetal Neonatal Med. 18, 286-297 (2013).